Loading company…
SynGen develops cell separation tools and accessories for regenerative medicine.
SynGen develops tools and accessories for separating and isolating therapeutic cells in regenerative medicine workflows. Its products are intended for researchers, clinical laboratories, and healthcare professionals. Based in San Carlos, US, the company raised USD 5.00 mn across funding rounds, including USD 2.50 mn in venture debt from GE Capital in October 2014.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in